Total Funding
32
29
Total FundingSeed raised
Growth Score
-1 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
227160
NMB Therapeutics is a pharmaceutical company that develops products to provide efficient drug delivery.
Murray Froikin: Chief Financial Officer & Chief Operating Officer- Dan Fisher: President & Co-Founder
About the Company
NMB Therapeutics is a pharmaceutical company that develops products to provide efficient drug delivery. It focuses on nanotechnology delivery of nitric oxide with its strategic partner's active ingredients to create enhanced pharmaceuticals to combat illness, disease, and other challenging medical issues, enabling pharmaceutical and
cosmeceutical companies on projects development that require enhanced therapeutic effects to achieve better results for patients and consumers.
The company was founded in 2018 and is based in Hempstead, New York.
